Your browser doesn't support javascript.
loading
Neuroprotective Effects of Ultra-High Dose Rate FLASH Bragg Peak Proton Irradiation.
Dokic, Ivana; Meister, Sarah; Bojcevski, Jovana; Tessonnier, Thomas; Walsh, Dietrich; Knoll, Maximilian; Mein, Stewart; Tang, Zili; Vogelbacher, Lena; Rittmueller, Claudia; Moustafa, Mahmoud; Krunic, Damir; Brons, Stephan; Haberer, Thomas; Debus, Jürgen; Mairani, Andrea; Abdollahi, Amir.
Affiliation
  • Dokic I; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Meister S; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Bojcevski J; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Tessonnier T; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Walsh D; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Knoll M; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Mein S; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Tang Z; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Vogelbacher L; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Rittmueller C; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Moustafa M; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Krunic D; Light Microscopy Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brons S; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Haberer T; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Debus J; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
  • Mairani A; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Abdollahi A; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Hei
Int J Radiat Oncol Biol Phys ; 113(3): 614-623, 2022 07 01.
Article in En | MEDLINE | ID: mdl-35196536
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiation Injuries / Neuroprotective Agents / Proton Therapy Limits: Animals Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiation Injuries / Neuroprotective Agents / Proton Therapy Limits: Animals Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2022 Document type: Article Country of publication: United States